Literature DB >> 16182977

Low plasma vasopressin/norepinephrine ratio predicts septic shock.

I-Yin Lin1, Hon-Ping Ma, Aming Chor-Ming Lin, Chee-Fah Chong, Chiu-Mei Lin, Tzong-Luen Wang.   

Abstract

To evaluate if low plasma vasopressin and high norepinephrine concentrations predict grave prognosis of sepsis, a prospective sample of consecutive patients visiting the emergency department of a university teaching hospital who met the American College of Chest Physicians criteria of sepsis or severe sepsis was enrolled. Besides septic workup, we measured serum vasopressin and norepinephrine concentrations to correlate the impending outcome. One hundred eighty-two patients aged 27 to 99 years met the inclusive criteria and were classified as those with septic shock (n = 72), severe sepsis (n = 56), and those with sepsis only (n = 54) according to the outcome within 6 hours. Thirty healthy subjects were included as control. The plasma vasopressin level at baseline was significantly lower for those who finally developed septic shock (septic shock group, 3.6 +/- 2.5 pg/mL; 95% confidence interval [CI], 3.0-4.2 pg/mL; severe sepsis group, 21.8 +/- 4.1 pg/mL, 95% CI, 20.7-22.9 pg/mL; sepsis group, 10.6 +/- 6.5 pg/mL, 95% CI, 8.8-12.4 pg/mL, P < .001), whereas the norepinephrine level was highest for the same group (septic shock group, 3650 +/- 980 pg/mL, 95% CI, 3420-3880 pg/mL; severe sepsis group, 3600 +/- 1000 pg/mL, 95% CI, 3330-3870 pg/mL; sepsis group, 1720 +/- 320 pg/mL, 95% CI, 1630-1810 pg/mL). The vasopressin/norepinephrine ratio was significantly lower for the patients with final diagnosis of septic shock (P < .001). The mean interval between the time of samples drawn and the time of the most severe occurring sequelae was 2.4 +/- 0.8 hours. Receiver operating characteristic analysis revealed that the vasopressin/norepinephrine ratio 1 x 10(-3) had a sensitivity of 97% (95% CI, 90%-99%) and a specificity of 85% (95% CI, 78%-91%) for detecting impending septic shock. Low serum vasopressin/norepinephrine ratio can predict impending septic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182977     DOI: 10.1016/j.ajem.2005.02.055

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

1.  Comment on "clinical impact of vasopressin infusion on hemodynamics, liver and renal function in pediatric patients".

Authors:  Sascha Meyer
Journal:  Intensive Care Med       Date:  2008-06-25       Impact factor: 17.440

Review 2.  Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum.

Authors:  Davide Tommaso Andreis; Mervyn Singer
Journal:  Intensive Care Med       Date:  2016-02-12       Impact factor: 17.440

Review 3.  Divergent neuroendocrine responses to localized and systemic inflammation.

Authors:  Mark K Lukewich; Richard C Rogers; Alan E Lomax
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

Review 4.  The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.

Authors:  Sascha Meyer; William McGuire; Sven Gottschling; Ghiath Mohammed Shamdeen; Ludwig Gortner
Journal:  Wien Med Wochenschr       Date:  2011-01-25

5.  Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin.

Authors:  Woan-Ching Jan; Ming-Chang Kao; Chen-Hsien Yang; Ya-Ying Chang; Chun-Jen Huang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

6.  Vasopressin: Its current role in anesthetic practice.

Authors:  Jayanta K Mitra; Jayeeta Roy; Saikat Sengupta
Journal:  Indian J Crit Care Med       Date:  2011-04

Review 7.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

8.  Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury.

Authors:  Sascha Meyer; Sven Gottschling; Ali Baghai; Donald Wurm; Ludwig Gortner
Journal:  Crit Care       Date:  2006-05-05       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.